Global Parkinson’s Disease Treatment market expected to reach $9.14 billion by 2033, driven by aging population and new treatments

From GlobeNewswire: 2024-06-24 15:00:00

The Parkinson’s Disease Treatment market is expected to grow from USD 4.91 billion in 2023 to USD 9.14 billion by 2033, with a CAGR of 6.41%. The market is driven by the aging population, increasing public awareness, and development of new treatments. The carbidopa-levodopa segment is anticipated to dominate the market, while North America is expected to hold the largest share. Hospital pharmacies are projected to grow at the fastest CAGR due to increased demand for therapy. In Asia Pacific, government funding and R&D efforts are expected to drive market growth. Several key vendors, including Abbott Laboratories and Pfizer, are involved in the global Parkinson’s Disease Treatment market. Recent developments include a partnership between ABL Bio Inc. and Sanofi to develop a new medication. The market is segmented by drug class, route of administration, and distribution channels, with North America, Europe, and Asia Pacific leading in market share. For more information and detailed analysis, visit: https://www.sphericalinsights.com/checkout/4618.



Read more at GlobeNewswire: Global Parkinson’s Disease Treatment Market Size To Worth